Archivio istituzionale della ricerca dell'Università degli Studi di Palermo
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, pubblicazioni, progetti, attività) adottato dall’Università di Palermo, e ha lo scopo di raccogliere, conservare, documentare, e diffondere ad accesso aperto le informazioni relative alla produzione scientifica degli autori afferenti all’Ateneo.
EnglishThis study was directed to assess the clinical impact of the circulating cathepsin L, cystatin C, activin A, and follistatin in breast cancer patients. The serum concentrations of these molecules were determined by immunoenzymatic assays, and their association with some clinico-pathological parameters of breast cancer progression was evaluated. Our results identified cystatin C and activin A as predictive markers for the presence of breast cancer and bone metastasis, respectively. Therefore, these proteins may have a clinical role as circulating biomarkers in the diagnosis and therapeutic monitoring of breast cancer patients.
Leto, G., Incorvaia, L., Flandina, C., Ancona, C., Fulfaro, F., Crescimanno, M., et al. (2016). Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report. CANCER INVESTIGATION, 34(9), 415-423.
| Data di pubblicazione: | 2016 | |
| Titolo: | Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report | |
| Autori: | ||
| Citazione: | Leto, G., Incorvaia, L., Flandina, C., Ancona, C., Fulfaro, F., Crescimanno, M., et al. (2016). Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report. CANCER INVESTIGATION, 34(9), 415-423. | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1080/07357907.2016.1222416 | |
| Abstract: | This study was directed to assess the clinical impact of the circulating cathepsin L, cystatin C, activin A, and follistatin in breast cancer patients. The serum concentrations of these molecules were determined by immunoenzymatic assays, and their association with some clinico-pathological parameters of breast cancer progression was evaluated. Our results identified cystatin C and activin A as predictive markers for the presence of breast cancer and bone metastasis, respectively. Therefore, these proteins may have a clinical role as circulating biomarkers in the diagnosis and therapeutic monitoring of breast cancer patients. | |
| Settore Scientifico Disciplinare: | Settore BIO/14 - Farmacologia | |
| Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Cancer Invest 2016.pdf | Articolo principale | Versione Editoriale | Administrator Richiedi una copia |
Copyright © 2022